China Pharma Holdings (CPHI) Short-term Investments (2019)

China Pharma Holdings (CPHI) reported Short-term Investments of $109908.0 for Q4 2019.

China Pharma Holdings (CPHI) Short-term Investments (2019) Analysis & Trends

China Pharma Holdings has reported Short-term Investments for 1 years, with the latest figure at $109908.0 in Q4 2019.

  • For the quarter ending Q4 2019, Short-term Investments changed N/A year-over-year to $109908.0; the trailing twelve-month figure through Dec 2019 stood at $109908.0 (changed N/A YoY), and the FY2019 full-year result was $109908.0, changed N/A from the prior year.
  • Short-term Investments for Q4 2019 stood at $109908.0.
  • The five-year high for Short-term Investments was $109908.0 in Q4 2019, with the low at $109908.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 China Pharma Holdings 18.87 Mn 18.70 Mn 285,487.00

Historic Data

Download Data
DateValue
Dec 31, 2019 109,908.00